News Bayer opens Berlin incubator and welcomes first resident Bayer's network of Co.Lab life sciences incubators has expanded once again with the official opening of a site in Berlin, its first in Europe
News Bayer adds a new life science incubator in China Bayer’s network of Co.Lab life sciences incubators has expanded once again with the announcement of a new site in Shanghai, China, that will focus on oncology cell and gen
News Bayer adds US life sciences incubator in Cambridge Bayer has formally opened a new life sciences incubator in Cambridge, Massachusetts, that will focus on cell and gene therapies (CGT).
News FDA clears Ionis drug as first therapy for rare disease FCS Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.